German Ott

76.7k total citations · 1 hit paper
336 papers, 12.9k citations indexed

About

German Ott is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, German Ott has authored 336 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 239 papers in Pathology and Forensic Medicine, 159 papers in Oncology and 92 papers in Genetics. Recurrent topics in German Ott's work include Lymphoma Diagnosis and Treatment (231 papers), Viral-associated cancers and disorders (101 papers) and Chronic Lymphocytic Leukemia Research (85 papers). German Ott is often cited by papers focused on Lymphoma Diagnosis and Treatment (231 papers), Viral-associated cancers and disorders (101 papers) and Chronic Lymphocytic Leukemia Research (85 papers). German Ott collaborates with scholars based in Germany, United States and Spain. German Ott's co-authors include Andreas Rosenwald, Hans Konrad Müller‐Hermelink, Elı́as Campo, Tiemo Katzenberger, Jörg Kalla, Michaela Ott, Randy D. Gascoyne, M. Michaela Ott, Elena Hartmann and Thomas Rüdiger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

German Ott

327 papers receiving 12.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

2013 372 citations Heike Horn, Marita Ziepert et al. Blood profile →

Peers

Countries citing papers authored by German Ott

Since Specialization

Citations

This map shows the geographic impact of German Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by German Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites German Ott more than expected).

Fields of papers citing papers by German Ott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by German Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by German Ott. The network helps show where German Ott may publish in the future.

Co-authorship network of co-authors of German Ott

This figure shows the co-authorship network connecting the top 25 collaborators of German Ott. A scholar is included among the top collaborators of German Ott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with German Ott. German Ott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Age‐ and gender‐specific molecular characteristics of diffuse large B‐cell lymphoma: Results from clinical trials of the DSHNHL/GLA 2025 ·HemaSphere ·Katrin S. Kurz, (unknown), Markus Kreuz, Marita Ziepert, Annette M. Staiger, Thomas F.E. Barth, Peter Mӧller, Heinz‐Wolfram Bernd, Alfred C. Feller, Julia Richter, Wolfram Klapper, Harald Stein, Sylvia Hartmann, Martin‐Leo Hansmann, Lorenz Trümper, Markus Loeffler, Norbert Schmitz, Andreas Rosenwald, German Ott, Heike Horn, (unknown)	0
2	Current practice of pathologic response assessment following chemoimmunotherapy for non‐small cell lung cancer ( NSCLC ) in Germany: first real‐world data from the multicentre Re‐ GraDE study 2025 ·Histopathology ·(unknown), Christiane Kümpers, German Ott, (unknown), (unknown), Annette Fisseler‐Eckhoff, Maximilian von Laffert, (unknown), (unknown), Dietmar Kraus, (unknown), F. Parkes Weber, Tamás Szőke, (unknown), Annette Arndt, (unknown), Hanibal Bohnenberger, (unknown), Christian Matek, Konrad Steinestel, (unknown)	0
3	Overview on WHO-HAEM5 and the diagnostic relevance of genetic alterations for the classification 2024 ·Medizinische Genetik ·Claudia Haferlach, German Ott, (unknown), (unknown), Torsten Haferlach, Reiner Siebert	1
4	Genetic alterations in mature B- and T-cell lymphomas – a practical guide to WHO-HAEM5 2024 ·Medizinische Genetik ·Cristina López, (unknown), (unknown), Reiner Siebert, German Ott, (unknown)	0
5	Lymphoma Classifications, How to Develop a Future Unified Taxonomy 2024 ·Journal of Clinical Oncology ·Elı́as Campo, Daan Dierickx, Stefan Dirnhofer, Kieron Dunleavy, Philippe Gaulard, Robert P. Hasserjian, Elaine S. Jaffe, (unknown), Rebecca L. King, Megan S. Lim, German Ott, Miguel Á. Piris, Gilles Salles, Reiner Siebert	7
6	Progression of follicular lymphoma and related entities: Report from the 2021 SH/EAHP Workshop 2023 ·American Journal of Clinical Pathology ·Amy S. Duffield, Ahmet Doǧan, Catalina Amador, James R. Cook, Magdalena Czader, John R. Goodlad, Reza Nejati, Wenbin Xiao, Lanie E. Happ, (unknown), (unknown), (unknown), Sandeep S. Davé, (unknown), German Ott	3
7	Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach 2023 ·Blood ·Catalina Amador, Dennis D. Weisenburger, Ana Gomez, Alyssa Bouska, Francisco Vega, James R. Cook, Timothy C. Greiner, Andrew L. Feldman, Elaine S. Jaffe, Sarah L. Ondrejka, German Ott, Neval Özkaya, Philipp W. Raess, Andreas Rosenwald, Kerry J. Savage, Graham W. Slack, Joo Y. Song, Lisa M. Rimsza, Wing C. Chan, Javeed Iqbal	1
8	Classifying Germinal Center Derived Lymphomas—Navigate a Complex Transcriptional Landscape 2022 ·Cancers ·Henry Loeffler‐Wirth, Markus Kreuz, (unknown), German Ott, Reiner Siebert, Hans Binder	10
9	Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma 2021 ·Proceedings of the National Academy of Sciences ·Marco Fangazio, Erik Ladewig, (unknown), Laura Garcia‐Ibanez, Rahul Kumar, Julie Teruya‐Feldstein, Davide Rossi, Ioan Filip, Qiang Pan‐Hammarström, Giorgio Inghirami, Renzo Boldorini, German Ott, Annette M. Staiger, Bjoern Chapuy, Gianluca Gaïdano, Govind Bhagat, Katia Basso, Raúl Rabadán, Laura Pasqualucci, Riccardo Dalla‐Favera	53
10	Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features 2021 ·British Journal of Haematology ·Julia Richter, Katharina John, Annette M. Staiger, Andreas Rosenwald, Katrin S. Kurz, (unknown), German Ott, Sören Franzenburg, Christian Köhler, (unknown), Ilske Oschlies, (unknown), Reiner Siebert, Rainer Spang, Birgit Burkhardt, Wolfram Klapper	16
11	A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma 2020 ·Clinical Cancer Research ·Santiago Demajo, (unknown), Guillem Clot, Giancarlo Castellano, Alba Navarro, (unknown), Anna Enjuanes, Ferran Nadeu, Eva Giné, Magda Pinyol, Elaine S. Jaffe, German Ott, Louis M. Staudt, Andreas Rosenwald, David W. Scott, Lisa M. Rimsza, Armando López‐Guillermo, Sı́lvia Beà, Elı́as Campo, Pedro Jares	10
12	Aggressive B‑Zell-Lymphome: Empfehlungen des Deutschen Panels der Referenzpathologen im Kompetenznetz Maligne Lymphome e. V. zum diagnostischen Vorgehen nach der aktuellen WHO-Klassifikation, Update 2017 2019 ·Der Pathologe ·Wolfram Klapper, Falko Fend, Alfred C. Feller, Martin L. Hansmann, Peter Mӧller, Harald Stein, Andreas Rosenwald, German Ott	1
13	High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology 2018 ·Blood ·David W. Scott, Rebecca L. King, Annette M. Staiger, Susana Ben‐Neriah, Aixiang Jiang, Heike Horn, Anja Mottok, Pedro Farinha, Graham W. Slack, Daisuke Ennishi, Norbert Schmitz, Michael Pfreundschuh, Grzegorz S. Nowakowski, Brad S. Kahl, Joseph M. Connors, Randy D. Gascoyne, German Ott, William R. Macon, Andreas Rosenwald	145
14	microRNA Expression Profiles Identify Subtypes of Mantle Cell Lymphoma with Different Clinicobiological Characteristics 2013 ·Clinical Cancer Research ·Alba Navarro, Guillem Clot, (unknown), Cristina Royo, Maria Carmela Vegliante, Virginia Amador, Elena Hartmann, Itziar Salaverría, Sı́lvia Beà, José I. Martı́n-Subero, Andreas Rosenwald, German Ott, Adrian Wiestner, Wyndham H. Wilson, Elı́as Campo, Luís Hernández	29
15	The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG) 2013 ·Blood ·Sylvia Hartmann, Dennis A. Eichenauer, Annette Plütschow, Anja Mottok, Roshanak Bob, Karoline Koch, Heinz‐Wolfram Bernd, Sergio Cogliatti, Michael Hummel, Alfred C. Feller, German Ott, Peter Mӧller, Andreas Rosenwald, Harald Stein, Martin‐Leo Hansmann, Andreas Engert, Wolfram Klapper	112
16	Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin 2012 ·Cancer Research ·(unknown), Meng Dong, (unknown), Godehard Friedel, (unknown), Andreas Grabner, German Ott, Thomas E. Mürdter, Moshe Oren, Walter E. Aulitzky, Heiko van der Kuip	24
17	Primary Follicular Lymphoma of the Duodenum Is a Distinct Mucosal/Submucosal Variant of Follicular Lymphoma: A Retrospective Study of 63 Cases 2011 ·Journal of Clinical Oncology ·(unknown), Berthold Streubel, Elisabeth Kretschmer‐Chott, Andreas Püspök, Ulrich Jäger, Christine Mannhalter, Markus Tiemann, German Ott, Wolfgang Fischbach, Peter Herzog, Gerhard Seitz, Manfred Stolte, Markus Raderer, Andreas Chott	152
18	MicroRNA Expression, Chromosomal Alterations, and Immunoglobulin Variable Heavy Chain Hypermutations in Mantle Cell Lymphomas 2009 ·Cancer Research ·Alba Navarro, Sı́lvia Beà, Verónica Fernández, (unknown), Itziar Salaverría, Pedro Jares, Elena Hartmann, Anna Mozos, Armando López‐Guillermo, Neus Villamor, Dolors Colomer, Xavier Puig, German Ott, Françesc Solé, Sergi Serrano, Andreas Rosenwald, Elı́as Campo, Luís Hernández	60
19	Five-Gene Model to Predict Survival in Mantle-Cell Lymphoma Using Frozen or Formalin-Fixed, Paraffin-Embedded Tissue 2008 ·Journal of Clinical Oncology ·Elena Hartmann, Verónica Fernández, Vı́ctor Moreno, Joan Valls, Luís Hernández, Francesc Bosch, Pau Abrisqueta, Wolfram Klapper, Martin Dreyling, Eva Hoster, Hans Konrad Müller‐Hermelink, German Ott, Andreas Rosenwald, Elı́as Campo	85
20	Diversity of Genomic Breakpoints in TFG-ALK Translocations in Anaplastic Large Cell Lymphomas 2002 ·American Journal Of Pathology ·Luís Hernández, Sı́lvia Beà, Beatríz Bellosillo, Magda Pinyol, Brunangelo Falini, Antonino Carbone, German Ott, Andreas Rosenwald, Alberto Fernández, Karen Pulford, David Y. Mason, Stephan W. Morris, Eugenio Santos, Elı́as Campo	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact